Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
2,156,744
-
Share change
-
+460,924
-
Total reported value
-
$48,817,902
-
Price per share
-
$22.63
-
Number of holders
-
59
-
Value change
-
+$10,336,199
-
Number of buys
-
24
-
Number of sells
-
24
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q4 2024
As of 31 Dec 2024,
ISHARES TR - GENOMICS IMMUN (IDNA) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,156,744 shares.
The largest 10 holders included
UBS Group AG, MORGAN STANLEY, Wharton Business Group, LLC, BANK OF AMERICA CORP /DE/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, FLOW TRADERS U.S. LLC, Clearwater Capital Advisors, LLC, Royal Bank of Canada, AMERIPRISE FINANCIAL INC, and Lido Advisors, LLC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.